A detailed history of Andra Ap Fonden transactions in Moderna, Inc. stock. As of the latest transaction made, Andra Ap Fonden holds 2,300 shares of MRNA stock, worth $151,225. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,300
Holding current value
$151,225
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$101.21 - $166.61 $232,783 - $383,203
2,300 New
2,300 $273,000
Q4 2023

Feb 15, 2024

BUY
$69.51 - $104.43 $2.35 Million - $3.53 Million
33,800 Added 57.29%
92,800 $9.23 Million
Q3 2023

Nov 09, 2023

SELL
$96.41 - $126.61 $308,512 - $405,152
-3,200 Reduced 5.14%
59,000 $6.09 Million
Q2 2023

Aug 09, 2023

BUY
$118.5 - $160.53 $1.59 Million - $2.15 Million
13,400 Added 27.46%
62,200 $7.56 Million
Q1 2023

May 12, 2023

BUY
$135.66 - $197.02 $2.71 Million - $3.94 Million
20,000 Added 69.44%
48,800 $7.49 Million
Q4 2022

Feb 13, 2023

SELL
$118.38 - $210.04 $804,984 - $1.43 Million
-6,800 Reduced 19.1%
28,800 $5.17 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $1.05 Million - $1.73 Million
8,900 Added 33.33%
35,600 $4.21 Million
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $35,139 - $52,977
-300 Reduced 1.11%
26,700 $3.81 Million
Q4 2021

Feb 15, 2022

BUY
$225.82 - $368.51 $1.49 Million - $2.43 Million
6,600 Added 32.35%
27,000 $6.86 Million
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $133,140 - $290,682
600 Added 3.03%
20,400 $7.85 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $2.57 Million - $4.65 Million
19,800 New
19,800 $4.65 Million
Q4 2020

Feb 12, 2021

SELL
$65.74 - $169.86 $1.43 Million - $3.69 Million
-21,700 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$54.34 - $94.85 $2.21 Million - $3.86 Million
-40,700 Reduced 65.22%
21,700 $1.54 Million
Q2 2020

Aug 06, 2020

BUY
$29.67 - $80.0 $1.85 Million - $4.99 Million
62,400 New
62,400 $4.01 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Andra Ap Fonden Portfolio

Follow Andra Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.